Before the lab: where NHS diagnostics really goes wrong
Traditionally, diagnostic quality is measured inside the laboratory: analyser performance, turnaround times, and accreditation. Yet the part of the journey nobody audits, the pre-analytical phase accounts for over 70% of diagnostic errors.
Between paper requests, samples with unverified transit times or temperatures, and the risk of Wrong Blood in a Tube (WBIT), operational flaws directly impact the patient. As care shifts into the community (Neighbourhood Health), addressing what happens before the tube reaches the analyser is the real priority set out by GIRFT.
At Salutare, we are focused on closing this gap through digitalisation, point-of-care verification, and end-to-end specimen tracking.
The Lab Isn’t Broken, The Handover Is: Rethinking Pre-Analytical Diagnostics in the NHS
Even the most advanced modern laboratory cannot produce an accurate result from a compromised or delayed blood sample.
Eliminating pre-analytical vulnerabilities at the point of care is crucial to ensuring diagnostic precision, protecting patient safety, and maximizing NHS clinical capacity.
Empowering Clinician-Led Innovation to Solve Core NHS Challenges
Healthcare innovation works best when it is engineered by the people who understand the patient journey intimately.
To truly transform services and improve patient outcomes, the NHS must create fertile ground for clinician-founders to develop, scale, and embed homegrown technologies directly into our care pathways.
No Patient Left Behind: Reimagining MDT Referrals in the NHS
How many patients are left behind in our healthcare system?
That’s the question crossing the minds of many healthcare professionals countless times.
Learn how ONE Referral Platform helps clinicians work safer and faster while making better informed decisions.
With Salutare ONE no patients are lost in the system.